Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA gyrase and DNA topoisomerase IV are two essential Type II topoisomerase enzymes found in bacteria. DNA gyrase primarily catalyzes the ATP-dependent introduction of negative supercoils into double-stranded DNA and is unique to bacteria. It plays a central role in resolving topological stress ahead of the replication fork during DNA replication, thus facilitating continued synthesis and genome maintenance[5][6]. DNA topoisomerase IV is responsible for decatenation, i.e., unlinking of interlinked (catenated) daughter chromosomes following DNA replication, and also helps relax positive supercoils[1][2][3][4]. Both enzymes function as heterotetramers: DNA gyrase is composed of GyrA and GyrB subunits, while topoisomerase IV consists of ParC and ParE subunits[1][4]. These enzymes are critical for bacterial viability and are prime targets for antibiotics, especially fluoroquinolones and related drugs, which trap enzyme-DNA complexes and induce lethal double-strand DNA breaks[3]. Resistance to these antibiotics frequently involves mutations in the genes encoding their subunits. Both enzymes are absent in higher eukaryotes (which have related topoisomerases but lack DNA gyrase specifically), making them attractive and selective antibacterial drug targets.
Inhibition of DNA supercoiling (gyrase) and decatenation (topoisomerase IV), leading to impaired DNA replication and segregation Stabilization of enzyme-DNA cleavage complexes, causing double-strand DNA breaks and cell death
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA gyrase and DNA topoisomerase IV.